Does the type of biomesh influence recurrence in abdominal wall reconstruction? A long-term follow-up to a randomized controlled trial
SummaryThis discussion describes the long-term follow-up of a prospective randomized controlled trial evaluating the performance of the 2 most common biomesh products utilized in the context of complex abdominal wall reconstructions. Although the incidence of hernia recurrence increased over time to 26% (median follow-up 62 mo), both biomesh products performed similarly. Biomesh product choice should remain cost-conscious.
Authors
- Chad G. Ball (ORCID: https://orcid.org/0000-0002-8839-6809)
- Andrew W. Kirkpatrick (ORCID: https://orcid.org/0000-0002-1692-5919)
- Thomas W. Clements (ORCID: https://orcid.org/0000-0001-9723-5196)
- Jaiden Punia
Institutions
- Merck Canada Inc. (Canada) (CA)
- Ball (France) (FR)
Publication Details
- Journal
- Canadian Journal of Surgery
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1503/cjs.011624
- Citations
- 1
- Primary Topic
- Hernia repair and management
- Type
- article
- Field-Weighted Citation Impact
- 0.57